GREM1 and pancreatic adenocarcinoma: Univariate Cox analysis across multiple cancer cohorts has shown that high GREM1 expression is significantly associated with poor prognosis, particularly in cancers like KIRC, KIRP, malignant MESO, PAAD, and STAD.